History, challenges and perspectives of cell microencapsulation

被引:267
作者
Orive, G
Hernández, RM
Gascón, AR
Calafiore, R
Chang, TMS
de Vos, P
Hortelano, G
Hunkeler, D
Lacík, I
Pedraz, JL [1 ]
机构
[1] Univ Basque Country, Fac Pharm, Lab Pharm & Pharmaceut Technol, Vitoria 01006, Spain
[2] Univ Perugia, Dept Internal Med, I-06126 Perugia, Italy
[3] McGill Univ, Fac Med, Artificial Cells & Organs Res Ctr, Montreal, PQ H3G 1Y6, Canada
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, Sect Med Biol, Groningen, Netherlands
[5] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
[6] AQUA TECH Specialties SA, CH-1283 Geneva, Switzerland
[7] Slovak Acad Sci, Inst Polymer, Dept Special Polymers & Biopolymers, Bratislava 84236, Slovakia
关键词
D O I
10.1016/j.tibtech.2003.11.004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cell microencapsulation continues to hold significant promise for biotechnology and medicine. The controlled, and continuous, delivery of therapeutic products to the host by immunoisolated cells is a potentially cost-effective method to treat a wide range of diseases. Although there are several issues that need to be addressed, including capsule manufacture, properties and performance, in the past few years, a stepwise analysis on the essential obstacles and limitations has brought the whole technology closer to a realistic proposal for clinical application. This paper summarizes the current situation in the cell encapsulation field and discusses the main events that have occurred along the way.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 45 条
[11]   Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane [J].
Duvivier-Kali, VF ;
Omer, A ;
Parent, RJ ;
O'Neil, JJ ;
Weir, GC .
DIABETES, 2001, 50 (08) :1698-1705
[12]   Parathyroid allotransplantation without immunosuppression [J].
Hasse, C ;
Klock, G ;
Schlosser, A ;
Zimmermann, U ;
Rothmund, M .
LANCET, 1997, 350 (9087) :1296-1297
[13]   Delivery of human factor IX in mice by encapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B [J].
Hortelano, G ;
AlHendy, A ;
Ofosu, FA ;
Chang, PL .
BLOOD, 1996, 87 (12) :5095-5103
[14]  
Hunkeler D, 2001, ANN NY ACAD SCI, V944, P456
[15]  
IWATA H, 1990, TRANSPLANT P, V22, P797
[16]   STRATEGY FOR DEVELOPING MICROBEADS APPLICABLE TO ISLET XENOTRANSPLANTATION INTO A SPONTANEOUS DIABETIC NOD MOUSE [J].
IWATA, H ;
TAKAGI, T ;
KOBAYASHI, K ;
OKA, T ;
TSUJI, T ;
ITO, F .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1994, 28 (10) :1201-1207
[17]   Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating [J].
King, A ;
Strand, B ;
Rokstad, AM ;
Kulseng, B ;
Andersson, A ;
Skjåk-Bræk, G ;
Sandler, S .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003, 64A (03) :533-539
[18]   Biocompatibility of mannuronic acid-rich alginates [J].
Klock, G ;
Pfeffermann, A ;
Ryser, C ;
Grohn, P ;
Kuttler, B ;
Hahn, HJ ;
Zimmermann, U .
BIOMATERIALS, 1997, 18 (10) :707-713
[19]   Encapsulated cell technology [J].
Lanza, RP ;
Hayes, JL ;
Chick, WL .
NATURE BIOTECHNOLOGY, 1996, 14 (09) :1107-1111
[20]   Human therapeutic cloning [J].
Lanza, RP ;
Cibelli, JB ;
West, MD .
NATURE MEDICINE, 1999, 5 (09) :975-977